Free Trial

Reckitt Benckiser Group (LON:RKT) Trading Up 0.2% - Still a Buy?

Reckitt Benckiser Group logo with Consumer Defensive background

Shares of Reckitt Benckiser Group plc (LON:RKT - Get Free Report) shot up 0.2% during mid-day trading on Thursday . The company traded as high as GBX 5,196 ($70.50) and last traded at GBX 5,162 ($70.04). 737,980 shares changed hands during mid-day trading, a decline of 83% from the average session volume of 4,263,184 shares. The stock had previously closed at GBX 5,150 ($69.88).

Reckitt Benckiser Group Price Performance

The company has a market capitalization of £35.09 billion, a PE ratio of 23.54, a P/E/G ratio of 1.10 and a beta of 0.09. The company has a debt-to-equity ratio of 110.26, a quick ratio of 0.46 and a current ratio of 0.69. The stock has a 50 day moving average price of GBX 4,903.58 and a two-hundred day moving average price of GBX 5,005.94.

Insider Activity

In other news, insider Kris Licht sold 3,799 shares of the business's stock in a transaction that occurred on Friday, March 21st. The stock was sold at an average price of GBX 5,177 ($70.24), for a total transaction of £196,674.23 ($266,857.84). Insiders own 0.05% of the company's stock.

About Reckitt Benckiser Group

(Get Free Report)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Further Reading

Should You Invest $1,000 in Reckitt Benckiser Group Right Now?

Before you consider Reckitt Benckiser Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.

While Reckitt Benckiser Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir at All-Time Highs: Take Profits or Hold the Line?
3 Tech Stocks Insiders Are Buying: Speculative Plays for June
3 Defense Stocks Set to Crush the S&P This Summer

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines